Video

New CAR T Clinical Trials Underway at Roswell Park for Solid Tumor, Non-cancerous Diseases

While the focus and promise of CAR T-cell therapies has long been on liquid tumors and hematologic malignancies, new trials under way at Roswell Park Comprehensive Cancer Center are expanding the applications of immunotherapy to include other diseases.

News

Investigators Hope for Potential Breakthrough in Dual Cellular Therapy Approach for Advanced and Metastatic Solid Tumors

Roswell Park Comprehensive Cancer Center is moving the science forward by offering clinical trials aimed at extending the benefits of those therapies to patients with all types of solid tumors.

News

Governor Hochul Celebrates Opening of New York’s First Cell and Gene Therapy Hub at Roswell Park Comprehensive Cancer Center In Buffalo

Governor Kathy Hochul today celebrated the opening of the Roswell Park GMP Engineering and Cell Manufacturing Facility, New York's first cell and gene therapy hub, located at Roswell Park Comprehensive Cancer Center in Buffalo.

Video

Graft Versus Host Disease No Longer Poses High Risk to Transplant Patients

Graft versus host disease (GVHD) used to present such a risk to transplant patients, an estimate 10-15% of patients would develop a fatal case of it.

News

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Congressman Kennedy announced $7,731,872 in funding for the Roswell Park Comprehensive Cancer Center to renovate its newly integrated biobank, the Roswell Park Biorepository, made possible through the Office of the Director of the National ...

News

Exclusive to Roswell Park, ‘Armored CAR’ Clinical Trial Targets CD19+ Hematologic Malignancies

A phase 1 clinical trial underway exclusively at Roswell Park Comprehensive Cancer Center will evaluate a novel chimeric antigen receptor (CAR) T-cell therapy for patients with relapsed or refractory hematologic malignancies whose tumor ...